| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 21st August 2020 | Holding, S.A. Biodyne | 75,000 | Open or private sale | $0.38 | $28,500.00 |
| 20th August 2020 | Holding, S.A. Biodyne | 75,000 | Open or private sale | $0.27 | $20,250.00 |
| 19th August 2020 | Holding, S.A. Biodyne | 50,000 | Open or private sale | $0.30 | $15,000.00 |
| 18th August 2020 | Holding, S.A. Biodyne | 50,000 | Open or private sale | $0.34 | $17,000.00 |
| 14th August 2020 | Holding, S.A. Biodyne | 50,000 | Open or private sale | $0.31 | $15,500.00 |
| 3rd August 2020 | Holding, S.A. Biodyne | 70,000 | Open or private sale | $0.32 | $22,400.00 |
| 31st July 2020 | Holding, S.A. Biodyne | 5,000 | Open or private sale | $0.34 | $1,700.00 |
| 30th July 2020 | Holding, S.A. Biodyne | 25,000 | Open or private sale | $0.32 | $8,000.00 |
| 21st July 2020 | Holding, S.A. Biodyne | 50,000 | Open or private sale | $0.45 | $22,500.00 |
| 20th July 2020 | Holding, S.A. Biodyne | 150,000 | Open or private sale | $0.43 | $64,500.00 |
Hancock Jaffe Laboratories
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.
Hancock Jaffe Laboratories, Inc. is a development stage medical device company. Its products include The Bioprosthetic Heart Valve, The CoreoGraft, and The Venous Valve.
Ticker: HJLI
Sector: Health Technology
Industry: Medical Specialties
SEC Central Index Key (CIK): 1661053
Employees: 12
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
We weren't able to import Fundamental data from the SEC disclosure.
There were no Red Flags found
Fundamentals
We weren't able to import Fundamental data from the SEC disclosure.
